The role of vitamin D in reducing SARS-CoV-2 infection: An update

Int Immunopharmacol. 2021 Aug:97:107686. doi: 10.1016/j.intimp.2021.107686. Epub 2021 Apr 17.

Abstract

The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is having a disastrous impact on global health. Recently, several studies examined the potential of vitamin D to reduce the effects of SARS-CoV-2 infection by modulating the immune system. Indeed, vitamin D has been found to boost the innate immune system and stimulate the adaptive immune response against SARS-CoV-2 infection. In this review, we provide a comprehensive update of the immunological mechanisms underlying the positive effects of vitamin D in reducing SARS-CoV-2 infection as well as a thorough survey of the recent epidemiological studies and clinical trials that tested vitamin D as a potential therapeutic agent against COVID-19 infection. We believe that a better understanding of the histopathology and immunopathology of the disease as well as the mechanism of vitamin D effects on COVID-19 severity will ultimately pave the way for a more effective prevention and control of this global pandemic.

Keywords: COVID-19; Immune response; Immunopathogenesis; SARS-CoV-2; Vitamin D.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity / drug effects
  • COVID-19 / etiology
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • Dietary Supplements
  • Humans
  • Immunity, Innate / drug effects
  • Seasons
  • Severity of Illness Index
  • Vitamin D / immunology
  • Vitamin D / metabolism
  • Vitamin D / pharmacology*
  • Vitamin D / therapeutic use*

Substances

  • Vitamin D